Cargando…

A comparison of drug‐eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure

AIMS: The best revascularization strategy for patients with ischaemic heart failure (IHF) remains unclear. Current evidence and guidelines mainly focus on patients with severe ischaemic heart failure (ejection fraction [EF] < 35%). There are limited data comparing clinical outcomes of coronary ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kun, Wang, Le, Cong, Hongliang, Zhang, Jingxia, Hu, Yuecheng, Zhang, Yingyi, Zhang, Rui, Li, Wenyu, Qi, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065860/ https://www.ncbi.nlm.nih.gov/pubmed/35194977 http://dx.doi.org/10.1002/ehf2.13852

Ejemplares similares

Clinical outcome comparison of percutaneous coronary intervention and bypass surgery in diabetic patients with coronary artery disease: a meta-analysis of randomized controlled trials and observational studies
por: Zhai, ChuanNan, et al.
Publicado: (2019)

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
por: Wang, Le, et al.
Publicado: (2021)

Long term outcomes of drug-eluting stent versus coronary artery bypass grafting for left main coronary artery disease: a meta-analysis
por: Cui, Kong-Yong, et al.
Publicado: (2018)

Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease
por: Xin, Xiaojun, et al.
Publicado: (2019)

Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis
por: Wang, Zhi, et al.
Publicado: (2020)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Chen, Xue, et al.
Publicado: (2020)

Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease
por: Naito, Ryo, et al.
Publicado: (2015)

Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
por: Kang, Se Hun, et al.
Publicado: (2017)

Coronary artery bypass grafting versus stents
por: Iglézias, JCR, et al.
Publicado: (2013)

The association between myocardial scar and the response of moderate ischemic mitral regurgitation to isolated coronary artery bypass grafting
por: Zhu, Enjun, et al.
Publicado: (2021)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Drug-eluting stents or coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of four randomized trials and seventeen observational studies
por: Li, Qing, et al.
Publicado: (2013)

Treatment of syphilitic aortitis with coronary artery bypass grafting and “open” stent placement
por: Tang, Tiansheng, et al.
Publicado: (2023)

Comparison of Bypass Surgery with Drug-Eluting Stents in Diabetic Patients with Left Main Coronary Stenosis
por: Zhao, Xiaoxiao, et al.
Publicado: (2011)

Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study
por: Li, Yang, et al.
Publicado: (2022)

Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction
por: Lang, Jiachun, et al.
Publicado: (2022)

Prediabetes is Associated with Worse Long-Term Outcomes in Young Patients with Acute Coronary Syndrome
por: Xu, Rongdi, et al.
Publicado: (2023)

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease
por: Papadopoulos, Kyriacos, et al.
Publicado: (2017)

Percutaneous coronary intervention using drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease an updated meta-analysis of randomized clinical trials
por: Gao, Lei, et al.
Publicado: (2017)

Mitral valve repair for ischemic moderate mitral regurgitation in patients undergoing coronary artery bypass grafting
por: Toktas, Faruk, et al.
Publicado: (2016)

Impact of prior coronary stenting on the outcome of subsequent coronary artery bypass grafting
por: Cheng, Yu-Ting, et al.
Publicado: (2017)

Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials
por: Ahmad, Yousif, et al.
Publicado: (2020)

Elderly Patients with Moderate Chronic Ischemic Mitral Regurgitation: Coronary Artery Bypass Grafting Alone or Concomitant Mitral Annuloplasty?
por: Ji, Qiang, et al.
Publicado: (2019)

Combining electrocardiographic criteria for predicting acute total left main coronary artery occlusion
por: Liu, Chunwei, et al.
Publicado: (2022)

Very Long-term Outcomes and Predictors of Percutaneous Coronary Intervention with Drug-eluting Stents Versus Coronary Artery Bypass Grafting for Patients with Unprotected Left Main Coronary Artery Disease
por: Yu, Xian-Peng, et al.
Publicado: (2016)

Comparison of Coronary Artery Bypass Grafting Combined With Mitral Valve Repair Versus Coronary Artery Bypass Grafting Alone in Patients With Moderate Ischemic Mitral Regurgitation: A Meta-Analysis
por: Sameer, Muhammad Ali, et al.
Publicado: (2023)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis
por: Zhai, Chuannan, et al.
Publicado: (2020)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Comparing mortality and myocardial infarction between coronary artery bypass grafting and drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis
por: Qi, Xiaolong, et al.
Publicado: (2014)

Experience of the management of coronary artery bypass graft only on moderate ischemic mitral regurgitation: A single-center retrospective study
por: Wang, Weitie, et al.
Publicado: (2019)

Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
por: Rodriguez, Alfredo E., et al.
Publicado: (2016)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Two Cases of Percutaneous Intervention for Coronary Artery Bypass Graft Anastomoses With Paclitaxel-Eluting Balloon Catheters
por: Uhm, Jae-Sun, et al.
Publicado: (2011)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j2l4rq1mulmnuhu2ur1vcn4831